Clinical application of transcatheter arterial chemoembolization combined with synchronous C-arm Cone-beam CT guided radiofrequency ablation in treatment of large hepatocellular carcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 3, 2013, Pages 1649-1654

  Wang, Zhi Jun ^a   Wang, Mao Qiang ^a   Duan, Feng ^a   Song, Peng ^a   Liu, Feng Yong ^a   Wang, Yan ^a   Yan, Jie Yu ^a   Li, Kai ^a   Yuan, Kai ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

C arm cone beam CT; Chemoembolization; Large HCC; Radiofrequency ablation; Synchronous

Indexed keywords

EID: 84880410612     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.3.1649     Document Type: Article

References (22)

1. Bruix J, Sherman M, Llovet JM, et al (2001). Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol, 35, 421-30.
2. Fan WZ, Yang JY, Lü MD, et al (2011). Transcatheter arterial chemoembolization plus percutaneous thermal ablation in large hepatocellular carcinoma: clinical observation of efficacy and predictors of prognostic factors. Zhonghua Yi Xue Za Zhi, 91, 2190-4.
3. Forner A, Llovet JM, Bruix J (2012). Hepatocellular carcinoma. Lancet, 379, 1245-55.
4. Gadaleta C, Catino A, Ranieri G, et al (2009). Single-step therapy -- feasibility and safety of simultaneous transarterial chemoembolization and radiofrequency ablation for hepatic malignancies. In Vivo, 23, 813-20.
5. Georgiades CS, Hong K, Geschwind JF, et al (2008). Radiofrequency ablation and chemoembolization for hepatocellular carcinoma. Cancer J, 14, 117-22.
6. Head HW, Dodd GD 3rd, Bao A, et al (2010). Combination radiofrequency ablation and intravenous radiolabeled liposomal Doxorubicin: imaging and quantification of increased drug delivery to tumors. Radiology, 255, 405-14.
7. Kang SG, Yoon CJ, Jeong SH, et al (2009). Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study. J Vasc Interv Radiol, 20, 1570-7.
8. Kim MH, Choi MS, Choi YS, et al (2006). Clinical features of liver abscess developed after radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma. Korean J Hepatol, 12, 55-64.
9. Lee MW, Kim YJ, Park SW, et al (2009). Percutaneous radiofrequency ablation of small hepatocellular carcinoma invisible on both ultrasonography and unenhanced CT: a preliminary study of combined treatment with transarterial chemoembolisation. Br J Radiol, 82, 908-15.
10. Lee MW, Kim YJ, Park SW, et al (2011). Biplane fluoroscopyguided radiofrequency ablation combined with chemoembolisation for hepatocellular carcinoma: initial experience. Br J Radiol, 84, 691-7.
11. Marín-Hargreaves G, Azoulay D, Bismuth H (2003). Hepatocellular carcinoma: surgical indications and results. Crit Rev Oncol Hematol, 47, 13-27.
12. Miyayama S, Yamashiro M, Okuda M, et al (2010). Chemoembolization for the treatment of large hepatocellular carcinoma. J Vasc Interv Radiol, 21, 1226-34.
13. Dhanasekaran R, Kooby DA, Staley CA, et al (2010). Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC). J Surg Oncol, 101, 476-80.
14. Shimada K, Sakamoto Y, Esaki M, et al (2008). Role of a hepatectomy for the treatment of large hepatocellular carcinomas measuring 10 cm or larger in diameter. Langenbecks Arch Surg, 393, 521-6.
15. Shiraishi R, Yamasaki T, Saeki I, et al (2008). Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma. Am J Clin Oncol, 31, 311-6.
16. Takaki H, Yamakado K, Nakatsuka A, et al (2007). Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas 5 cm or smaller: risk factors for local tumor progression. J Vasc Interv Radiol, 18, 856-61.
17. Takaki H, Yamakado K, Uraki J, et al (2009). Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm. J Vasc Interv Radiol, 20, 217-24.
18. Veltri A, Moretto P, Doriguzzi A, et al (2006). Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol, 16, 661-9.
19. Wang W, Shi J, Xie WF (2010). Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis. Liver Int, 30, 741-9.
20. Yamakado K, Nakatsuka A, Ohmori S, et al (2002). Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology. J Vasc Interv Radiol, 13, 1225-32.
21. Yamakado K, Nakatsuka A, Takaki H, et al (2010). Subphrenic versus nonsubphrenic hepatocellular carcinoma: combined therapy with chemoembolization and radiofrequency ablation. AJR Am J Roentgenol, 194, 530-5.
22. Zangos S, Eichler K, Balzer JO, et al (2007). Large-sized hepatocellular carcinoma (HCC): a neoadjuvant treatment protocol with repetitive transarterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT). Eur Radiol, 17, 553-63.